During the past decade, Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council" #1 sponsor was "Pfizer" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Corvus Pharmaceuticals, Inc." with 1 trials sponsored, "First Wave BioPharma, Inc." with 1 trials sponsored and "Immutep S.A.S." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council" #1 collaborator was "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council" are "COVID-19" (2 trials), "Hematologic Neoplasms" (2 trials), "Neoplasms" (2 trials), "Advanced Malignancies" (1 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council" in a lesser frequency.

Most popular intervention types in "Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Encorafenib" (2 trials), "Pembrolizumab" (2 trials), "Placebo" (2 trials), "5-FU" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".